Home Contact Center Add this

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

Fuse N(1), Bando H(2), Chin K(3), Ito S(4), Yoshikawa T(5), Tsuburaya A(5), Terashima M(6), Kawashima Y(7), Fukunaga T(8), Gotoh M(9), Emi Y(10), Yoshida K(11), Oki E(12), Takahashi S(13), Kuriki H(14), Sato K(14), Sasako M(15).

Gastric Cancer. 2016 Mar 8. [Epub ahead of print]

  1. Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. nofuse@east.ncc.go.jp.
  2. Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  3. Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  4. Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.
  5. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  6. Division of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  7. Division of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
  8. Department of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kanagawa, Japan.
  9. Cancer Chemotherapy Center, Osaka Medical College, Osaka, Japan.
  10. Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
  11. Department of Surgical Oncology, Graduate School of Medicine, Gifu University, Gifu, Japan.
  12. Department of Surgery and Science, Kyusyu University Hospital, Fukuoka, Japan.
  13. Pharmaceutical Research and Development Department, Yakult Honsha Co., Ltd., Tokyo, Japan.
  14. Clinical Science and Strategy Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  15. Upper GI Division, Department of Surgery, Hyogo College of Medicine, Hyogo, Japan.